… New Delhi, July 24 (IANS) Giving a fillip to … Singh. The institute, under the department of biotechnology, ministry of science and technology, will be … organisation and be set up with an investment of Rs.2.03 billion. The cabinet also approved …
Original post by EIN News: India Biotech News
… in Asia Pacific. The emerging markets of India, China and Korea had strong double-digit growth. … — The company won six Life Science Industry Awards, the most of any company. The … by the industry’s customers — scientists in biotechnology and pharmaceutical companies, in government and academia. …
Original post by EIN News: India Biotech News
… Follow-on Investment from Canaan Partners and SVB India Capital Partners iYogi Secures $9.5M in Series … has a successful track record of building industry-leading companies by partnering with outstanding entrepreneurs and … CleanTech, networking, semiconductor, enterprise software and services, biotechnology and medical technologies to build next-generation market …
Original post by EIN News: India Biotech News
… — a remote technical support provider from India — raised $9.5 million in Series B … has a successful track record of building industry-leading companies by partnering with outstanding entrepreneurs and … CleanTech, networking, semiconductor, enterprise software and services, biotechnology and medical technologies to build next-generation market …
Original post by EIN News: India Biotech News
… Haydon, KBP chairman, said Wednesday. “But the business would be there to support it.” “This … to open up markets in China and India.” Those two countries have a combined population … that KBP is working with a dozen biotech companies on products at its bioprocessing facility. …
Original post by EIN News: India Biotech News
… strengthened analytical and environmental instrument capabilities in India, and expanded bioreagents portfolio for life sciences … serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, … effect of rapid changes in the healthcare industry. While we may elect to update forward-looking …
Original post by EIN News: India Biotech News
… C-section procedures. Second-quarter revenue for the Genetics business increased 7 percent to $78.5 million from … also began building a commercial organization in India, initiatives that reflect the companys commitment to … About Genzyme One of the world’s leading biotechnology companies, Genzyme is dedicated to making a …
Original post by EIN News: India Biotech News
… C-section procedures. Second-quarter revenue for the Genetics business increased 7 percent to $78.5 million from … also began building a commercial organization in India, initiatives that reflect the companys commitment to … rights reserved. One of the world’s leading biotechnology companies, Genzyme is dedicated to making a …
Original post by EIN News: India Biotech News
… globe in more than 40 countries including India for providing water treatment solutions, a top … such as power, chemical, processing, microelectronics, pharmaceuticals, biotech, food & beverages besides water supply & … technologies, a global leader in water treatment business with a turnover of around 2.1 billion …
Original post by EIN News: India Biotech News
… strengthened analytical and environmental instrument capabilities in India, and expanded bioreagents portfolio for life sciences … serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, … effect of rapid changes in the healthcare industry. While we may elect to update forward-looking …
Original post by EIN News: India Biotech News
… some fairly chunky acquisitions. With valuations of biotechnology and fledgling drug developers tumbling, this looks … emerging economies of South America, China and India. It has signed a pay-as-you go contract … the UK giant deviate from its usual business plan and sell cheap branded generic drugs …
Original post by EIN News: India Biotech News
… launch of the Sheffield Hallam University (SHU) India Office in July 2008, the University on … a twinning arrangement in business management. IILM Delhi and Gurgaon- funds have been allocated under … including hospitality management, engineering, business and management, biotechnology etc. Twinning agreements already exist in IT …
Original post by EIN News: India Biotech News
… markets in Asia Pacific, notably China and India, continued to drive growth, more than offsetting … the most diversified portfolios in the seeds industry covering corn, soybean, oilseeds, sugar beet, vegetables … will capture a wide range of future biotech opportunities. The development of a fully traited …
Original post by EIN News: India Biotech News
… excess of long-term growth targets, and Research Biotech exceeded current year growth expectations, all after … growth in our primary focus markets of India, Brazil and China ranged from 10% to … delivery at , but recent economic and industry conditions and discussions with customers have led …
Original post by EIN News: India Biotech News
… 7:15 pm ICT by IANS - New Delhi, July 23 (IANS) Industry forums Wednesday urged … seeds. Agriculture yield can accelerate only when India gears up for another Green Revolution by … another Green Revolution by applying nano and biotechnology in the farm sector, said Jindal. Seeking …
Original post by EIN News: India Biotech News
… household. Tramadol cheap no rx free from india. Myxedema coma usually from a few minutes … was developed by Icos, a relatively small biotech company has established.
Original post by EIN News: India Biotech News
… Industry lobby submits ‘reforms agenda’ to PM Industry … seeds. ‘Agriculture yield can accelerate only when India gears up for another Green Revolution by … another Green Revolution by applying nano and biotechnology in the farm sector,’ said Jindal. Seeking …
Original post by EIN News: India Biotech News
… Bernstein provides information about Generex Oral-lyn(TM), the biotechnology company’s oral insulin rapid-mist spray product that … product is currently on the market in India and Ecuador. To watch the segment online … the Generex website at The Generex Biotechnology Corp. logo is available at This release and …
Original post by EIN News: India Biotech News
… Biocon, a Bangalore-based biotech major, which partnered the Council of Scientific … institute through a NIMITLI (the New Millennium India Technology Leadership Initiative) project, has developed a … to catalyse innovation in India and promote industry-academia linkages. "The enzyme project started in April …
Original post by EIN News: India Biotech News
… From correspondents in Delhi, India, 10:54 PM IST To celebrate the … the launch of the Sheffield Hallam University India Office in July 2008, the University announced … including hospitality management, engineering, business and management, biotechnology etc. Twinning agreements already exist in IT …
Original post by EIN News: India Biotech News
… the contract research company reported weaker new business gains than expected in the second quarter, … boom in business from big pharma and biotech outsourcing and emerging markets like China and India. Wall Street has kept a mainly positive …
Original post by EIN News: India Biotech News
… been expecting a stronger boost in new business and a lower cancellation rate. Shares slipped … boom in business from big pharma and biotech outsourcing and emerging markets like China and India. Wall Street has kept a mainly positive …
Original post by EIN News: India Biotech News
… Design & Patenting, Pharma QA & QC, Biotechnology etc (I-Newswire) - Established in 2002 Bioinformatics … - Established in 2002 Bioinformatics Institute of India ( BII ) is a reputed and … its areas of expertise. Our Distance Participation Industry programs are our most popular programs. Working …
Original post by EIN News: India Biotech News
… by the KBW Bank Index. The Amex Biotechnology Index and the S&P Retail Index gained … Asia-Pacific region rallied on Wednesday, led by India, after Wall Street rebounded overnight following a … of speculation about merger activity in the industry and a drop in oil prices. The …
Original post by EIN News: India Biotech News
… reforms process is urgently sought by the industry chamber include agriculture, labour (without hire and … further. The yields could accelerate only when India gears up for the second green revolution … revolution with application of nano technology and biotechnology. This, according to ASSOCHAM, is possible through …
Original post by EIN News: India Biotech News
… C-section procedures. Second-quarter revenue for the Genetics business increased 7 percent to $78.5 million from … also began building a commercial organization in India, initiatives that reflect the company’s commitment to … About Genzyme One of the world’s leading biotechnology companies, Genzyme is dedicated to making a …
Original post by EIN News: India Biotech News
… excess of long-term growth targets, and Research Biotech exceeded current year growth expectations, all after … growth in our primary focus markets of India, Brazil and China ranged from 10% to … June 30, 2008, but recent economic and industry conditions and discussions with customers have led …
Original post by EIN News: India Biotech News
… European Union External Trade Commissioner by developed-nation industry associations call potential amendments to the WTO … on the part of representatives mainly from biotechnology and pharmaceutical industries who generally agree that … specimens from a Singalila National Park in India. It is illegal under Indian law to …
Original post by EIN News: India Biotech News
… Health Advocates in Pune, India, points out. “India is a classic case where you have … vaccines a matter of public health urgency. Biotechnology companies took the hint, and since then, … person in.” John believes the Indian pharmaceutical industry could play a role in delivering affordable …
Original post by EIN News: India Biotech News
… It reflects the crop protection and some biotechniques. ‘Pages’ has close relationship with ‘yellow pages’, … vertical, which provides more individualized and specific industry services for the specific customers. Agropages is … such as Buyerguidechem.com (Germany), Chembuyersguide.com (US), Chemicalweekly.com (India) and BCPC.org (UK). Agropages is and only …
Original post by EIN News: India Biotech News
… excess of long-term growth targets, and Research Biotech exceeded current year growth expectations, all after … growth in our primary focus markets of India, Brazil and China ranged from 10% to … June 30, 2008, but recent economic and industry conditions and discussions with customers have led …
Original post by EIN News: India Biotech News
… excess of long-term growth targets, and Research Biotech exceeded current year growth expectations, all after … growth in our primary focus markets of India, Brazil and China ranged from 10% to … June 30, 2008, but recent economic and industry conditions and discussions with customers have led …
Original post by EIN News: India Biotech News
… excess of long-term growth targets, and Research Biotech exceeded current year growth expectations, all after … growth in our primary focus markets of India, Brazil and China ranged from 10% to … June 30, 2008, but recent economic and industry conditions and discussions with customers have led …
Original post by EIN News: India Biotech News
… Policy 2. Legal/Patent 3. Economic & Financial 4. Regulatory & Technical Who Should Attend: Pharma/Biotech Industry from the USA, Europe, Japan, India, Singapore, China, Israel, and other countries with biotech and generic biotech organizations: Legal Affairs …
Original post by EIN News: India Biotech News
… Manufacturers of America (PhRMA), the most influential industry association of multinational drug companies in the … of the Organization of Pharmaceutical Producers of India (OPPI). PhRMA, which represents leading American pharmaceutical … which represents leading American pharmaceutical research and biotechnology companies, also insists its members to follow …
Original post by EIN News: India Biotech News
… crore for the five-year nano mission, the industry can get the much-needed boost. The setting … also come forward to join hands with India to set up the EU-India Co-ordinated Call … and ICICI Ventures have invested heavily on biotech products but have stayed away from the …
Original post by EIN News: India Biotech News
… named. At 31.5 million bales last year, India is the worlds second largest cotton producer. … a genetically modified variety developed by US biotechnology company Monsanto Co., was introduced. Prices have jumped …
Original post by EIN News: India Biotech News
… medicine. “According to figures from the Basic Industry Ministry’s pharmaceutical group, Cuba earned some $350 … of some 180 medicines,” Cuba’s generic and biotechnology products include vaccines for type B meningococcal … Cuba has joint ventures with South Africa, India and China, as well as joint development …
Original post by EIN News: India Biotech News
… From correspondents in Andhra Pradesh, India, 10:00 PM IST GVK Biosciences, a leading … this exciting time of the company and industry and I look forward to this association,’ … integrated research services to big pharma and biotech companies globally. The company has more than …
Original post by EIN News: India Biotech News
… projected to reach $72 billion by 2009 (Business Communications Co., Inc., February 2005). Infinity Medical … many of the world’s leading pharmaceutical and biotechnology companies, earlier today announced $5.0 million of … with Encorium (i) a CRO based in India with over 10 years of clinical trial …
Original post by EIN News: India Biotech News
Guest content from Nicolaj H. Nielsen, managing director of Biostrat.
A case-study on the recent licensing-deal between Myriad and Lundbeck: Information asymmetry, calculated bets and royalties in the biotech industry.
The share-price of Lundbeck has fallen with approximately 10 %, since the Danish pharmaceutical company announced an inlicensing deal with the US biotech company Myriad for a new drug named Flurizan aimed against mild Alzheimer. Why do investors not like the deal, and could the deal be (yet another) good sign for biotech companies?
What we know…
Flurizan has completed phase II and the results from the two ongoing phase III studies will not be known until June 2008. Lundbeck will pay Myriad USD 100 million for the European commercialization rights + milestone payments + royalties in the range of 20-39 % of sales.
Lundbeck has clearly taken a calculated bet. Lundbeck believes so much in Flurizan that the company is willing to pay a large sum of money before the phase III data is known. The company is thereby trying to avoid a bidding-war against Big Pharma after positive phase III data, but is at the same time taking significant financial risk.
Why is the Market so skeptical?
Biotech is maybe the industry with the largest degree of information asymmetry. Biotech companies simply know much more about the strength and weaknesses of a potential product than outside investors/partners. This has been proven again and again by the lack of shareholder value creation in investment funds - even those that are managed by highly specialized investment companies.
The market believes that the information asymmetry is also in play in the Flurizan deal. If data from the ongoing phase III studies are so promising, why is Myriad outlicensing the product before the phase III data is available? Such a decision could of course be explained by a risk-minimizing strategy by Myriad – but again, if Myriad believes so much in the product, why not take the risk and wait 4 weeks for the data to be available?
The price…
The other thing that worries the market is the price of the drug. Taking the calculated bet could of course be defended if the acquisition price and royalties are very low. Many investors believe that not only have Lundbeck just spent USD 100 million on the roulette, but even if successful – the product will be very expensive for Lundbeck.
The parties have announced that Lundbeck will pay royalties in the range of 20-39 % of sales, which seems very high com compared to industry standards.
We don’t know the details of the agreement, and are therefore not in a position to judge whether the price is too high or not. We can just conclude that the market has voted with its feet, and the share-price has fallen with close to 10 % since the announcement. The market believes that Lundbeck’s bet is not generating shareholder-value.
Is the Myriad-deal good news for biotech companies in general?
We believe that the Myriad deal is yet another sign that the power between (inlicensing) Pharma companies and (outlicensing) biotech-companies are shifting to the favor of the latter.
In a time where many biotech companies, especially the companies with many early-stage projects, are struggling to get new funding, it is encouraging to see how good terms it is possible to negotiate only with phase II data. Most Pharma companies, like Lundbeck, is struggling to fill out their pipeline. The fight over good potential products is constantly getting tougher and tougher – for the benefit of biotech companies with the “right” products in their pipeline.
About the author:
This analysis was written by Nicolaj H. Nielsen, managing director of Biostrat, which provides management consulting services to the biotech industry.
Original post by biostrat
… sensitive shipping solutions for the frozen biopharmaceutical industry, today announced the extreme conditions testing in India is currently ongoing. “The results of our … for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed …
Original post by EIN News: India Biotech News
… is a growing trend in the pharmaceutical industry towards the use of disposable autoinjectors, incorporating … technologies and outsourcing services to pharmaceutical and biotechnology companies. Under the terms of this agreement, … and markets them globally, with focus on India, US, Europe and Russia. The Company conducts …
Original post by EIN News: India Biotech News
… sensitive shipping solutions for the frozen biopharmaceutical industry, today announced the extreme conditions testing in India is currently ongoing. “The results of our … for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed …
Original post by EIN News: India Biotech News
… sensitive shipping solutions for the frozen biopharmaceutical industry, today announced the extreme conditions testing in India is currently ongoing. “The results of our … for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed …
Original post by EIN News: India Biotech News
… many of the world’s leading pharmaceutical and biotechnology companies, today announced $5.0 million of new business contracts with several multinational as well as … with Encorium (i) a CRO based in India with over 10 years of clinical trial …
Original post by EIN News: India Biotech News
… spendings on Nano tech at US$7mn: ASSOCHAM India Infoline News Service / Mumbai Jul 22, … to The Associated Chambers of Commerce and Industry of India (ASSOCHAM). Amazingly, India also fares … as China are investing hugely in the biotechnology sector and are attracting investors worldwide. Cheap …
Original post by EIN News: India Biotech News
… HYDERABAD, India, Jul 22, 2008 (BUSINESS WIRE) — GVK … this exciting time of the Company and Industry and I look forward to this association.” … integrated research services to big Pharma and Biotech companies globally. The company accelerates the Drug …
Original post by EIN News: India Biotech News
… expects $3 billion in sales from the business within five years. The company’s annual profit … supply. 11. Suzlon Energy, traded in Mumbai, India, under ticker 532667, is another wind-turbine manufacturer … NZYM-B — one of the world’s biggest biotech companies. The company’s a leader in sustainability, …
Original post by EIN News: India Biotech News
… part in an electronic products show in India to help local businesses make inroads into … to play an important role in the biotechnology industry if the nation can effectively integrate its …
Original post by EIN News: India Biotech News
